These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6821809

  • 1. Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma.
    Lipton A, Harvey HA, Lawrence B, Gottlieb R, Kukrika M, Dixon R, Graham W, Miller S, Heckard R, Schelzel D, White DS.
    Cancer; 1983 Jan 01; 51(1):57-60. PubMed ID: 6821809
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
    Koh HK, Sober AJ, Harmon DC, Lew RA, Carey RW.
    Med Pediatr Oncol; 1985 Jan 01; 13(5):244-60. PubMed ID: 3897817
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ.
    Can Med Assoc J; 1983 Jun 01; 128(11):1291-5. PubMed ID: 6342739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.
    Murray JL, Ishmael DR, Bottomley RH, Grozea PN, Lee ET.
    Cancer Treat Rep; 1983 Feb 01; 67(2):191-2. PubMed ID: 6825130
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant therapy of melanoma.
    Agarwala SS, Kirkwood JM.
    Semin Surg Oncol; 1998 Jun 01; 14(4):302-10. PubMed ID: 9588723
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
    Henz BM, Macher E, Bröcker EB, Suciu S, Steerenberg PA, Jung E, Rümke P.
    Dermatology; 1996 Jun 01; 193(2):105-9. PubMed ID: 8884144
    [Abstract] [Full Text] [Related]

  • 12. Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum.
    Hilal EY, Pinsky CM, Hirshaut Y, Wanebo HJ, Hansen JA, Braun DW, Fortner JG, Oettgen HF.
    Cancer; 1981 Jul 15; 48(2):245-51. PubMed ID: 7016302
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant BCG immunotherapy for malignant melanoma.
    Paterson AH, Willans DJ, Jerry LM, Hanson J, McPherson TA.
    Can Med Assoc J; 1984 Oct 01; 131(7):744-8. PubMed ID: 6383591
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S, Takita H, Kuberka N, Preisler H, Catane H, Higby D, Henderson E.
    Cancer Treat Rep; 1978 Apr 01; 62(4):505-10. PubMed ID: 350388
    [Abstract] [Full Text] [Related]

  • 15. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results.
    Clunie GJ, Gough IR, Dury M, Furnival CM, Bolton PM.
    Cancer; 1980 Aug 01; 46(3):475-9. PubMed ID: 6994866
    [Abstract] [Full Text] [Related]

  • 16. Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781).
    Czarnetzki BM, Macher E, Suciu S, Thomas D, Steerenberg PA, Rümke P.
    Eur J Cancer; 1993 Aug 01; 29A(9):1237-42. PubMed ID: 8343260
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
    Byrne MJ, Van Hazel G, Reynolds PM, Lemish WM, Holman CD.
    J Surg Oncol; 1983 Jun 01; 23(2):114-6. PubMed ID: 6343725
    [Abstract] [Full Text] [Related]

  • 20. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N, Crowther D.
    Dev Biol Stand; 1983 Jun 01; 38():449-53. PubMed ID: 608536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.